0,797  0,011  Caspase 9 stimulant
0,743  0,004  Antimutagenic
0,702  0,005  UGT1A6 substrate
0,723  0,027  Apoptosis agonist
0,695  0,004  Superoxide dismutase inhibitor
0,694  0,007  CTGF expression inhibitor
0,699  0,021  Antineoplastic (breast cancer)
0,683  0,007  NOS2 expression inhibitor
0,685  0,009  Sensitization
0,680  0,008  UGT1A9 substrate
0,667  0,004  Skin whitener
0,665  0,016  GST A substrate
0,649  0,008  Antioxidant
0,650  0,009  Cardiovascular analeptic
0,638  0,004  Melanin inhibitor
0,629  0,008  Lipoxygenase inhibitor
0,625  0,007  Free radical scavenger
0,624  0,028  Transcription factor NF kappa B inhibitor
0,616  0,023  TNF expression inhibitor
0,601  0,010  Antineoplastic (non-small cell lung cancer)
0,593  0,005  Monophenol monooxygenase inhibitor
0,584  0,004  UGT2B4 substrate
0,586  0,008  Amyloid beta aggregation inhibitor
0,606  0,029  Antineoplastic (lung cancer)
0,600  0,024  Antileukemic
0,593  0,019  Prostate cancer treatment
0,586  0,014  12-Lipoxygenase inhibitor
0,578  0,015  CYP2D6 substrate
0,559  0,005  Sulfotransferase substrate
0,569  0,026  Antineoplastic (colorectal cancer)
0,545  0,003  Prostaglandin EP2 antagonist
0,560  0,026  Antineoplastic (colon cancer)
0,548  0,014  Caspase 3 stimulant
0,531  0,004  VCAM1 expression inhibitor
0,542  0,015  Ulceration
0,527  0,006  UGT1A3 substrate
0,539  0,019  Radioprotector
0,536  0,020  Antineoplastic (melanoma)
0,528  0,017  AR expression inhibitor
0,516  0,009  UGT1A1 substrate
0,527  0,023  CYP2C19 substrate
0,520  0,020  Antineoplastic (cervical cancer)
0,558  0,065  Antiinflammatory
0,511  0,018  Chemopreventive
0,489  0,004  Alpha tubulin antagonist
0,504  0,027  Histamine release inhibitor
0,499  0,024  CYP1A2 substrate
0,499  0,027  Antineoplastic (ovarian cancer)
0,499  0,033  Aldehyde oxidase inhibitor
0,473  0,009  Tubulin antagonist
0,487  0,023  Chemoprotective
0,471  0,014  Antihypertriglyceridemic
0,468  0,013  Antihypoxic
0,471  0,019  CYP1A2 inhibitor
0,457  0,005  UGT2B15 substrate
0,480  0,029  Antihypercholesterolemic
0,465  0,019  ICAM1 expression inhibitor
0,475  0,031  CYP2C19 inhibitor
0,481  0,040  CYP2C9 substrate
0,455  0,019  Antipyretic
0,440  0,014  Antiulcerative
0,472  0,047  15-Lipoxygenase inhibitor
0,434  0,013  Transcription factor STAT inhibitor
0,422  0,005  Breast cancer-resistant protein inhibitor
0,440  0,024  Antiprotozoal (Leishmania)
0,426  0,011  Antiseptic
0,443  0,029  Apoptosis antagonist
0,421  0,010  Genotoxic
0,416  0,009  Amylase inhibitor
0,411  0,005  5-Lipoxygenase inhibitor
0,427  0,023  Hypoglycemic
0,412  0,008  GST P1-1 substrate
0,445  0,042  Vasodilator, peripheral
0,417  0,014  P-glycoprotein inhibitor
0,431  0,031  NOS3 expression inhibitor
0,429  0,032  Antineoplastic (brain cancer)
0,422  0,026  Proliferative diseases treatment
0,399  0,009  Lipid peroxidase inhibitor
0,408  0,020  UDP-glucuronosyltransferase substrate
0,392  0,005  SULT1A3 substrate
0,418  0,034  Antineoplastic (pancreatic cancer)
0,406  0,025  Nitric oxide antagonist
0,391  0,010  Pneumotoxic
0,404  0,025  Cardiodepressant
0,391  0,013  Antihypotensive
0,409  0,034  Antineoplastic (glioma)
0,427  0,054  Immunosuppressant
0,400  0,028  Antiamyloidogenic
0,381  0,010  Tyrosine 3 hydroxylase inhibitor
0,425  0,057  Antipruritic, allergic
0,369  0,005  Cystathionine beta-synthase inhibitor
0,397  0,039  Cardioprotectant
0,371  0,017  GST M1-1 substrate
0,372  0,019  UGT1A4 substrate
0,370  0,027  Sigma receptor agonist
0,393  0,051  Bone diseases treatment
0,389  0,048  5 Hydroxytryptamine release stimulant
0,351  0,011  NOS3 expression enhancer
0,363  0,026  Peroxidase inhibitor
0,340  0,005  Carbonic anhydrase XIII inhibitor
0,365  0,031  Antineoplastic (osteosarcoma)
0,371  0,038  Hypoxia-inducible factor 1 alpha inhibitor
0,360  0,029  Transcription factor STAT3 inhibitor
0,373  0,045  Vasodilator, coronary
0,362  0,035  Antineoplastic (lymphoma)
0,358  0,031  Vasodilator
0,346  0,019  Antiviral (Herpes)
0,364  0,041  Calcium channel activator
0,370  0,051  Respiratory analeptic
0,331  0,012  Antihelmintic (Nematodes)
0,397  0,078  Antibacterial
0,358  0,040  Antineoplastic (multiple myeloma)
0,364  0,047  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,352  0,035  Antineoplastic (renal cancer)
0,396  0,080  5 Hydroxytryptamine release inhibitor
0,382  0,070  GABA C receptor rho-3 antagonist
0,346  0,037  Antineoplastic (glioblastoma multiforme)
0,323  0,015  Protein-tyrosine phosphatase inhibitor
0,311  0,004  UGT2B10 substrate
0,309  0,005  Choleretic
0,413  0,109  Alpha-glucosidase inhibitor
0,305  0,003  Prostaglandin EP3 antagonist
0,308  0,008  Interleukin 1b antagonist
0,350  0,053  Lipoprotein disorders treatment
0,322  0,031  Abortion inducer
0,300  0,011  Protein-tyrosine phosphatase 1B inhibitor
0,311  0,023  DNA methyltransferase I inhibitor
0,303  0,017  Neurotrophic factor enhancer
0,323  0,042  Pyruvate kinase inhibitor
0,301  0,020  MAO inhibitor
0,292  0,011  Antifungal enhancer
0,335  0,054  Antiosteoporotic
0,286  0,006  SULT1A1 substrate
0,285  0,006  Carbonic anhydrase III inhibitor
0,282  0,005  Beta tubulin antagonist
0,272  0,004  Papain-like protease (SARS coronavirus) inhibitor
0,294  0,028  UGT2B7 substrate
0,291  0,031  DNA methylase inhibitor
0,281  0,021  Insulin sensitizer
0,292  0,035  Anesthetic general
0,262  0,005  Keratolytic
0,330  0,074  Cholesterol antagonist
0,265  0,009  Farnesoid X receptor antagonist
0,328  0,073  Antithrombotic
0,325  0,074  FMO1 substrate
0,265  0,018  Succinate dehydrogenase inhibitor
0,343  0,096  Antiprotozoal
0,336  0,090  CYP2C9 inhibitor
0,252  0,008  Beta glucuronidase inhibitor
0,294  0,051  Antiglaucomic
0,262  0,019  MAO A inhibitor
0,270  0,027  Antineoplastic (squamous cell carcinoma)
0,308  0,067  Spasmolytic
0,260  0,019  Cyclooxygenase 1 inhibitor
0,264  0,024  Nitric-oxide synthase stimulant
0,309  0,069  Analeptic
0,308  0,069  Antineoplastic (small cell lung cancer)
0,272  0,033  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,255  0,019  Heat shock protein 90 antagonist
0,244  0,009  Estrogen antagonist
0,326  0,091  Prostaglandin dehydrogenase inhibitor
0,285  0,054  Hypolipemic
0,236  0,005  Prostaglandin E2 antagonist
0,251  0,023  Phospholipase A2 inhibitor
0,256  0,027  Interferon gamma antagonist
0,239  0,013  Xanthine oxidase inhibitor
0,245  0,019  Interleukin 1 antagonist
0,317  0,092  CYP3A4 substrate
0,246  0,023  LDLR expression enhancer
0,257  0,034  CYP2B6 inhibitor
0,247  0,027  Protein kinase stimulant
0,275  0,056  Cytotoxic
0,229  0,010  Carbonic anhydrase VI inhibitor
0,237  0,019  VEGF expression inhibitor
0,231  0,014  Carbonic anhydrase XV inhibitor
0,219  0,003  UGT2B11 substrate
0,277  0,061  Antineoplastic (liver cancer)
0,269  0,055  5 Hydroxytryptamine 1E antagonist
0,273  0,061  5 Hydroxytryptamine uptake stimulant
0,224  0,013  UGT2B1 substrate
0,257  0,047  Platelet adhesion inhibitor
0,214  0,005  Leukotriene antagonist
0,275  0,067  Radiosensitizer
0,238  0,031  Heat shock protein 90 alpha antagonist
0,335  0,129  Calcium channel L-type activator
0,212  0,009  Vanilloid 1 agonist
0,210  0,009  Estrogen receptor beta antagonist
0,259  0,058  Interleukin antagonist
0,222  0,022  Cholesterol synthesis inhibitor
0,212  0,012  Dementia treatment
0,220  0,021  Chelator
0,269  0,071  Antiprotozoal (Trypanosoma)
0,207  0,009  TRPA1 agonist
0,255  0,059  Antiparasitic
0,239  0,047  Hepatoprotectant
0,234  0,042  Antipruritic, non-allergic
0,250  0,059  Psychostimulant
0,273  0,082  FMO3 substrate
0,203  0,012  Vascular dementia treatment
0,212  0,022  MAO B inhibitor
0,214  0,029  Neurotensin receptor agonist
0,189  0,004  SULT1A2 substrate
0,227  0,042  Amyloid beta precursor protein antagonist
0,194  0,010  Prolactin inhibitor
0,187  0,004  Leukotriene B4 antagonist
0,200  0,019  Cyclooxygenase 3 inhibitor
0,233  0,052  Antihelmintic
0,209  0,029  Antirickettsial
0,209  0,030  Carcinogenic, group 1
0,190  0,010  NAD(P)H dehydrogenase (quinone) inhibitor
0,230  0,052  Non-steroidal antiinflammatory agent
0,204  0,025  Glutathione S-transferase substrate
0,213  0,037  Cyclooxygenase inhibitor
0,186  0,009  Heat shock protein 70 antagonist
0,198  0,022  Carcinogenic, group 2B
0,262  0,086  Insulysin inhibitor
0,206  0,033  Uterine stimulant
0,188  0,015  Gastritis treatment
0,216  0,044  Tumour necrosis factor antagonist
0,256  0,084  Huntington's disease treatment
0,181  0,010  DOPA decarboxylase inhibitor
0,204  0,034  Antidiarrheal
0,191  0,022  Expectorant
0,193  0,024  Interleukin 4 antagonist
0,192  0,024  Antihemorrhagic
0,176  0,009  SULT1E1 substrate
0,246  0,082  Antineoplastic (bladder cancer)
0,184  0,021  Coagulant
0,174  0,012  Transcription factor STAT6 inhibitor
0,199  0,037  Phobic disorders treatment
0,186  0,026  Antibacterial (Helicobacter pylori)
0,273  0,114  Antineoplastic (endocrine cancer)
0,233  0,075  Cytostatic
0,234  0,078  Angiogenesis stimulant
0,241  0,085  DNA damaging
0,307  0,151  Transcription factor inhibitor
0,197  0,041  Antidote
0,191  0,036  M18 aspartyl aminopeptidase inhibitor
0,164  0,012  Antifungal (Pneumocystis)
0,184  0,032  Toll-Like receptor 2 antagonist
0,229  0,078  Neuropeptide Y2 antagonist
0,215  0,065  Carcinogenic
0,170  0,020  Topoisomerase II alpha inhibitor
0,172  0,022  Mucolytic
0,187  0,041  Carcinogenic, group 3
0,184  0,039  GABA C receptor rho-2 antagonist
0,180  0,036  CF transmembrane conductance regulator agonist
0,155  0,011  Estrogen receptor alpha antagonist
0,164  0,019  Sphingomyelinase inhibitor
0,154  0,011  Estrogen agonist
0,218  0,075  Antimitotic
0,192  0,050  Phospholipase C inhibitor
0,159  0,018  Histidine decarboxylase inhibitor
0,158  0,017  Toll-Like receptor 4 antagonist
0,188  0,048  Antineoplastic (carcinoma)
0,172  0,033  Adenylate cyclase stimulant
0,245  0,106  Streptokinase A inhibitor
0,195  0,057  Dual specificity phosphatase inhibitor
0,176  0,040  Skin irritative effect
0,217  0,082  Antiviral (West Nile virus)
0,149  0,013  Peroxisome proliferator-activated receptor gamma agonist
0,207  0,072  Septic shock treatment
0,177  0,044  Alkaline phosphatase inhibitor
0,158  0,025  Potassium channel (Ca-activated) activator
0,219  0,087  Antineoplastic (lymphocytic leukemia)
0,174  0,042  Acetylcholinesterase inhibitor
0,176  0,043  Bone formation stimulant
0,174  0,042  Neurotrophic factor
0,187  0,056  Eye irritation, high
0,147  0,016  Macrophage migration inhibitory factor inhibitor
0,146  0,015  Carbonic anhydrase V inhibitor
0,156  0,026  Aldehyde dehydrogenase substrate
0,161  0,032  Microtubule formation inhibitor
0,220  0,092  Aryl hydrocarbon receptor agonist
0,155  0,030  Alpha 2c adrenoreceptor antagonist
0,207  0,082  ErbB-1 antagonist
0,224  0,099  Interleukin agonist
0,293  0,169  DNA polymerase beta inhibitor
0,135  0,011  Bile acid receptor antagonist
0,220  0,098  Antineoplastic (sarcoma)
0,141  0,020  Thioredoxin inhibitor
0,134  0,014  Carbonic anhydrase VA inhibitor
0,174  0,055  UGT2B9 substrate
0,176  0,058  Arachidonic acid antagonist
0,189  0,072  Mutagenic
0,147  0,030  AMP-activated protein kinase stimulant
0,131  0,015  Myeloperoxidase inhibitor
0,152  0,038  Ca2+-transporting ATPase inhibitor
0,141  0,026  Electron transport complex I inhibitor
0,142  0,028  HIV-1 integrase (Overall Integration) inhibitor
0,234  0,121  Antifungal
0,122  0,008  Estradiol 17 beta-dehydrogenase inhibitor
0,132  0,020  Antiviral (Rhinovirus)
0,120  0,011  Xanthine dehydrogenase inhibitor
0,129  0,020  Ornithine decarboxylase inhibitor
0,249  0,140  Antiprotozoal (Plasmodium)
0,285  0,177  Antidiabetic
0,285  0,177  Cyclophilin D inhibitor
0,111  0,004  Transcription factor RelA inhibitor
0,111  0,005  Glucose-6-phosphate translocase inhibitor
0,161  0,056  Antiprotozoal (Coccidial)
0,124  0,018  HIV-1 integrase (3'-Processing) inhibitor
0,121  0,016  Potassium channel large-conductance Ca-activated activator
0,136  0,031  Creatine kinase inhibitor
0,132  0,027  Antispirochetal
0,125  0,020  Glutathione S-transferase inhibitor
0,114  0,010  Endocannabinoid uptake inhibitor
0,236  0,134  Angiogenesis inhibitor
0,277  0,175  DNA directed DNA polymerase inhibitor
0,149  0,048  Antihelmintic (Trematoda)
0,145  0,045  Growth stimulant
0,112  0,012  Neuraminidase inhibitor
0,124  0,024  Antifungal (Aspergillus)
0,205  0,106  Vascular (periferal) disease treatment
0,109  0,011  Transcription factor AP-1 inhibitor
0,142  0,043  Antineoplastic (uterine cancer)
0,153  0,055  Antifungal (Cryptococcus)
0,108  0,010  Estrogen receptor beta agonist
0,115  0,018  Leukotriene synthesis inhibitor
0,107  0,012  Antitreponemal
0,139  0,044  Alpha 2b adrenoreceptor antagonist
0,137  0,043  Alcohol dehydrogenase substrate
0,107  0,013  Potassium channel (ATP-sensitive) blocker
0,132  0,038  Mediator release inhibitor
0,107  0,014  Neuraminidase (influenza) inhibitor
0,153  0,061  CNS active muscle relaxant
0,101  0,008  Estrogen receptor alpha agonist
0,270  0,178  Antiarthritic
0,236  0,144  Sodium/bile acid cotransporter inhibitor
0,180  0,088  Antiviral (Influenza)
0,108  0,017  Estrogen-related receptor beta agonist
0,111  0,020  GABA aminotransferase inhibitor
0,166  0,076  ATPase inhibitor
0,278  0,188  Alzheimer's disease treatment
0,190  0,100  Teratogen
0,098  0,011  Carbonic anhydrase XIV inhibitor
0,132  0,045  Photosensitizer
0,141  0,054  Topoisomerase II inhibitor
0,096  0,009  Potassium channel Kv1.3 blocker
0,194  0,109  RNA-directed DNA polymerase inhibitor
0,101  0,016  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,101  0,017  Postmenopausal disorders treatment
0,124  0,041  Urease inhibitor
0,096  0,013  Peroxisome proliferator-activated receptor alpha agonist
0,186  0,105  Cyclic AMP phosphodiesterase inhibitor
0,099  0,017  Prostaglandin antagonist
0,127  0,045  GABA C receptor agonist
0,105  0,024  Thioredoxin reductase inhibitor
0,110  0,031  Interleukin 5 antagonist
0,189  0,110  Platelet antagonist
0,134  0,055  Antiprotozoal (Amoeba)
0,098  0,019  Anticholelithogenic
0,104  0,025  Lipase inhibitor
0,135  0,057  Aldehyde dehydrogenase inhibitor
0,105  0,028  Vanilloid agonist
0,124  0,047  Antihelmintic (Fasciola)
0,099  0,023  HIV-1 integrase (Strand Transfer) inhibitor
0,119  0,043  Antiviral (SARS coronavirus)
0,119  0,043  Antiviral (Coronavirus)
0,117  0,042  Anabolic
0,159  0,084  Muscle relaxant
0,134  0,060  Cathepsin H inhibitor
0,121  0,047  Acetylcholine release stimulant
0,081  0,007  Leukotriene C antagonist
0,112  0,038  Androgen antagonist
0,093  0,020  Peroxisome proliferator-activated receptor gamma antagonist
0,163  0,090  Antineoplastic (bone cancer)
0,090  0,018  Beta 3 adrenoreceptor antagonist
0,105  0,033  Inducible nitric-oxide synthase inhibitor
0,075  0,004  Leukotriene B4 receptor 1 antagonist
0,109  0,038  Actinic keratosis treatment
0,130  0,061  DNA polymerase I inhibitor
0,087  0,018  SULT2A1 substrate
0,077  0,008  Pregnane X receptor antagonist
0,077  0,008  Factor III inhibitor
0,082  0,014  Sphingosine kinase 2 inhibitor
0,087  0,020  Carbonic anhydrase VB inhibitor
0,091  0,024  GABA B receptor agonist
0,087  0,022  Beta adrenoreceptor antagonist
0,106  0,042  Paget's disease treatment
0,098  0,034  Na+ K+ transporting ATPase inhibitor
0,176  0,112  Antineoplastic enhancer
0,100  0,035  Granulocyte macrophage colony stimulating factor agonist
0,132  0,068  Cyclooxygenase 2 inhibitor
0,096  0,032  Glutamate decarboxylase inhibitor
0,185  0,121  Peptidyltransferase inhibitor
0,109  0,047  Nitric-oxide synthase inhibitor
0,125  0,062  Contraceptive female
0,078  0,016  Heme oxygenase stimulant
0,140  0,079  Sphingosine 1-phosphate receptor 5 antagonist
0,132  0,070  Cocaine dependence treatment
0,086  0,025  Aromatase inhibitor
0,168  0,107  Embryotoxic
0,103  0,043  Alpha 2d adrenoreceptor antagonist
0,092  0,033  Histone deacetylase stimulant
0,092  0,033  Histone deacetylase SIRT1 stimulant
0,077  0,018  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,090  0,031  HIV-1 integrase inhibitor
0,083  0,025  5 Hydroxytryptamine 2A agonist
0,067  0,009  Inosine monophosphate dehydrogenase inhibitor
0,088  0,030  Glycine receptor agonist
0,123  0,065  Beta amyloid protein antagonist
0,065  0,007  Vesicle monoamine transporter inhibitor
0,094  0,037  D-Ala-D-Ala ligase inhibitor
0,138  0,081  Acaricide
0,062  0,006  Kainate receptor agonist
0,074  0,018  Postcoital contraceptive
0,181  0,126  Tumour necrosis factor alpha release inhibitor
0,108  0,053  GABA C receptor rho-1 antagonist
0,061  0,007  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,068  0,014  Heparanase inhibitor
0,120  0,067  Anesthetic local
0,155  0,102  Wound healing agent
0,075  0,022  Beta 1 adrenoreceptor antagonist
0,139  0,088  Acute respiratory distress syndrome (ARDS) treatment
0,076  0,025  Aldose reductase inhibitor
0,152  0,102  Antineoplastic (gastric cancer)
0,087  0,037  CDC25A inhibitor
0,077  0,029  Aryl hydrocarbon receptor antagonist
0,053  0,004  Inosine monophosphate dehydrogenase 2 inhibitor
0,115  0,067  Caspase 3 inhibitor
0,197  0,150  Antipsoriatic
0,140  0,093  Movement disorders treatment
0,096  0,049  Glutamate release inhibitor
0,066  0,019  Beta 2 adrenoreceptor antagonist
0,054  0,008  Leukotriene C4 antagonist
0,125  0,079  Antiprotozoal (Trichomonas)
0,067  0,022  Ryanodine receptor antagonist
0,085  0,040  Narcotic antagonist
0,124  0,079  Anesthetic
0,049  0,004  Leukotriene B4 receptor 2 antagonist
0,104  0,059  Butyrylcholinesterase inhibitor
0,061  0,017  Adenylate cyclase 1 inhibitor
0,057  0,012  Dihydrofolate reductase inhibitor
0,138  0,094  Hexokinase inhibitor
0,111  0,067  Myasthenia Gravis treatment
0,080  0,037  Phenylalanine 4-hydroxylase inhibitor
0,105  0,063  GST T1-1 substrate
0,120  0,078  Alpha-N-acetylglucosaminidase inhibitor
0,050  0,008  Prostaglandin EP4 antagonist
0,048  0,007  Prostaglandin EP1 antagonist
0,069  0,029  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,143  0,103  Dual specificity phosphatase 3 inhibitor
0,105  0,065  Antiprotozoal (Toxoplasma)
0,067  0,028  Sphingosine kinase inhibitor
0,050  0,011  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,059  0,020  Carbonic anhydrase VII inhibitor
0,107  0,068  GABA C receptor antagonist
0,087  0,049  Adrenaline agonist
0,092  0,054  Antidote, mercury
0,118  0,081  Antihyperlipoproteinemic
0,081  0,044  MAP kinase kinase 7 inhibitor
0,060  0,023  Vanilloid 2 antagonist
0,090  0,053  Tocolytic
0,046  0,009  ATP citrate lysase inhibitor
0,073  0,037  Glutamate (mGluR7) antagonist
0,170  0,135  5 Hydroxytryptamine 3E antagonist
0,058  0,023  Squalene epoxidase inhibitor
0,068  0,034  Antimycoplasmal
0,115  0,081  Sphingosine 1-phosphate receptor 4 antagonist
0,066  0,031  Alcohol oxidase inhibitor
0,127  0,095  Skeletal muscle relaxant
0,075  0,043  Purinergic P2X2 antagonist
0,070  0,038  CDC25B inhibitor
0,166  0,135  Antiviral (Ebola)
0,070  0,039  Uterine relaxant
0,128  0,098  Cholinergic
0,048  0,019  Dopamine D5 agonist
0,059  0,030  Dihydroorotate oxidase inhibitor
0,082  0,054  Ca(v)3.1 blocker
0,070  0,042  Exportin-1 inhibitor
0,045  0,018  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,039  0,012  Estrogen-related receptor beta antagonist
0,064  0,038  Purinergic P2X1 antagonist
0,046  0,020  Retinoid X receptor agonist
0,135  0,109  Liver fibrosis treatment
0,042  0,016  Peroxisome proliferator-activated receptor delta agonist
0,125  0,099  Antiviral (Influenza A)
0,122  0,097  Antiischemic, cerebral
0,042  0,018  Vanilloid 3 antagonist
0,066  0,042  Protease 3C (Human rhinovirus) inhibitor
0,111  0,088  Antiviral (Influenza B)
0,033  0,010  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,120  0,097  Sphingosine 1-phosphate receptor 2 antagonist
0,029  0,007  Retinoic acid alpha receptor antagonist
0,084  0,062  Transcription factor NF kappa B stimulant
0,062  0,041  Beta 2 adrenoreceptor agonist
0,086  0,065  ATPase (Vacuolar H+) inhibitor
0,050  0,030  Dopamine beta hydroxylase inhibitor
0,040  0,020  Retinoid X alpha receptor agonist
0,036  0,016  Prostaglandin agonist
0,073  0,053  Antibiotic
0,038  0,018  Sodium-dependent vitamin C transporter 2 inhibitor
0,081  0,062  Carcinogenic, group 2A
0,072  0,053  Catalase inhibitor
0,182  0,163  Flavin-containing monooxygenase substrate
0,081  0,062  Antiviral (Dengue virus)
0,084  0,066  NADH dehydrogenase inhibitor
0,029  0,011  CYP24 inhibitor
0,044  0,026  DNA gyrase subunit A inhibitor
0,130  0,113  Mcl-1 antagonist
0,076  0,060  Antineoplastic antibiotic
0,092  0,076  Antifungal (Candida)
0,039  0,024  Retinoid X receptor antagonist
0,080  0,065  NMDA receptor antagonist
0,051  0,036  Anesthetic inhalation
0,090  0,075  Phosphodiesterase 6D inhibitor
0,053  0,039  Thromboxane antagonist
0,035  0,022  HMG CoA reductase inhibitor
0,070  0,057  Alpha 2a adrenoreceptor antagonist
0,023  0,009  Retinoic acid receptor antagonist
0,033  0,021  Squalene synthetase inhibitor
0,049  0,038  H+/K+-transporting ATPase inhibitor
0,060  0,050  Dopamine D1 antagonist
0,085  0,075  ABCA1 expression enhancer
0,181  0,171  CYP2D6 inhibitor
0,090  0,081  Gout treatment
0,049  0,040  Aconitate hydratase inhibitor
0,089  0,081  Gastric antisecretory
0,032  0,024  Estrogen-related receptor alpha antagonist
0,025  0,017  Sodium/glucose cotransporter 1 inhibitor
0,022  0,015  Peroxisome proliferator-activated receptor alpha antagonist
0,030  0,023  Prostaglandin D2 agonist
0,020  0,014  Inosine monophosphate dehydrogenase 1 inhibitor
0,057  0,051  Prostaglandin F2 alpha antagonist
0,026  0,019  Sodium/glucose cotransporter 2 inhibitor
0,032  0,026  Peroxisome proliferator-activated receptor delta antagonist
0,158  0,153  Myocardial infarction treatment
0,037  0,031  Retinoic acid alpha receptor agonist
0,013  0,007  Retinoic acid beta receptor antagonist
0,037  0,031  GABA uptake inhibitor
0,019  0,014  Progesterone receptor B antagonist
0,074  0,069  Calcium antagonist
0,031  0,026  Catechol O-methyltransferase inhibitor
0,013  0,007  Retinoic acid receptor gamma antagonist
0,023  0,017  Prostaglandin E2 agonist
0,022  0,017  ICAM 1 antagonist
0,049  0,044  Maillard reaction inhibitor
0,053  0,049  Botulinum neurotoxin type A inhibitor
0,032  0,028  Retinoid X alpha receptor antagonist
0,018  0,015  Antibiotic Anthracycline-like
0,084  0,081  Bronchodilator
0,044  0,041  Glucose-6-phosphate isomerase inhibitor
0,085  0,082  UDP-glucose 4-epimerase inhibitor
0,023  0,021  Leukotriene D4 antagonist
0,039  0,037  Cholesterol absorption inhibitor
0,081  0,079  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,021  0,019  Retinoic acid gamma receptor agonist
0,043  0,042  Thromboxane A2 antagonist
0,093  0,092  Multidrug resistance-associated protein 1 inhibitor
0,019  0,019  Neuraminidase (Influenza B) inhibitor
0,081  0,081  Uric acid excretion stimulant

